WO1994002507A3 - Methods for detecting pre-clinical iddm - Google Patents
Methods for detecting pre-clinical iddm Download PDFInfo
- Publication number
- WO1994002507A3 WO1994002507A3 PCT/CA1993/000304 CA9300304W WO9402507A3 WO 1994002507 A3 WO1994002507 A3 WO 1994002507A3 CA 9300304 W CA9300304 W CA 9300304W WO 9402507 A3 WO9402507 A3 WO 9402507A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- iddm
- detecting pre
- clinical iddm
- clinical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93917471A EP0652898A1 (en) | 1992-07-28 | 1993-07-28 | Methods for detecting pre-clinical iddm |
AU46932/93A AU4693293A (en) | 1992-07-28 | 1993-07-28 | Methods for detecting pre-clinical iddm |
JP6504052A JPH07509232A (en) | 1992-07-28 | 1993-07-28 | How to detect IDDM before symptoms appear |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2074790 CA2074790A1 (en) | 1992-07-28 | 1992-07-28 | Methods for detecting pre-clinical iddm |
CA2,074,790 | 1992-07-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994002507A2 WO1994002507A2 (en) | 1994-02-03 |
WO1994002507A3 true WO1994002507A3 (en) | 1994-03-17 |
Family
ID=4150211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA1993/000304 WO1994002507A2 (en) | 1992-07-28 | 1993-07-28 | Methods for detecting pre-clinical iddm |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0652898A1 (en) |
JP (1) | JPH07509232A (en) |
AU (1) | AU4693293A (en) |
CA (1) | CA2074790A1 (en) |
WO (1) | WO1994002507A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995029936A1 (en) * | 1994-05-03 | 1995-11-09 | Hsc Research And Development Limited Partnership | Methods for controlling t lymphocyte mediated immune responses |
FR2740223B1 (en) * | 1995-10-19 | 1997-11-14 | Commissariat Energie Atomique | METHOD FOR DETERMINING AUTO-ANTIBODIES REVEALING PATHOLOGICAL COMPLICATIONS; IN THE BLOOD SERUM, PARTICULARLY DIABETICS |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992003733A1 (en) * | 1990-08-17 | 1992-03-05 | University Of Florida | Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
-
1992
- 1992-07-28 CA CA 2074790 patent/CA2074790A1/en not_active Abandoned
-
1993
- 1993-07-28 JP JP6504052A patent/JPH07509232A/en not_active Expired - Lifetime
- 1993-07-28 AU AU46932/93A patent/AU4693293A/en not_active Abandoned
- 1993-07-28 EP EP93917471A patent/EP0652898A1/en not_active Withdrawn
- 1993-07-28 WO PCT/CA1993/000304 patent/WO1994002507A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992003733A1 (en) * | 1990-08-17 | 1992-03-05 | University Of Florida | Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
Non-Patent Citations (4)
Title |
---|
ANNALS OF MEDICINE, vol. 24, no. 4, 1991, pages 447 - 452 * |
C. MACCRINDLE ET AL.: "Particle Concentration Fluorescence Immunoassay: A New Immunoassay Technique for Quantification of Human Immunoglobulins in Serum", CLINICAL CHEMISTRY, vol. 31, no. 9, September 1985 (1985-09-01), WINSTON US, pages 1487 - 1490 * |
CHEMICAL ABSTRACTS, vol. 116, no. 23, 8 June 1992, Columbus, Ohio, US; abstract no. 233099, J.M. MARTIN ET AL.: "Milk Proteins in the etiology of insulin-dependent diabetes mellitus (IDDM)" * |
J. KARJALAINEN ET AL.: "A Bovine Albumin Peptide as a Possible Trigger of Insulin-Dependent Diabetes Mellitus", NEW ENGLAND JOURNAL OF MEDICINE, vol. 327, no. 5, 30 July 1992 (1992-07-30), BOSTON, US, pages 302 - 307 * |
Also Published As
Publication number | Publication date |
---|---|
JPH07509232A (en) | 1995-10-12 |
CA2074790A1 (en) | 1994-01-29 |
WO1994002507A2 (en) | 1994-02-03 |
EP0652898A1 (en) | 1995-05-17 |
AU4693293A (en) | 1994-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2032907A1 (en) | Hepatitis c assay | |
ZA882998B (en) | Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans | |
HK1120865A1 (en) | Prognostic allergy test | |
ZA855031B (en) | Assay for simultaneous detection of antigen and antibody in given serum | |
EP1318401A3 (en) | Method for the early detection of the seroconversion of an anti hepatitis C virus antibody | |
TW222686B (en) | ||
KR950008537A (en) | Diagnostic Agents for Detection of Antibodies Against Epstein Bacillus (EBV) | |
FI930106A0 (en) | CENP-B epitope | |
GR3005971T3 (en) | ||
IT8023609A0 (en) | COMPOSITIONS SUITABLE FOR SEPARATING RED BLOOD BLOODS FROM SERUM OR PLASMA IN BLOOD SAMPLES FOR ANALYSIS AND THE METHOD THAT USES THEM. | |
WO1999043703A8 (en) | Method for immunochemically assaying anti-hm1.24 antibody | |
WO1994002507A3 (en) | Methods for detecting pre-clinical iddm | |
AU2353188A (en) | A diagnostic agent and a method for the determination of apolipoprotein b | |
EP0245052A3 (en) | Detection of inflammation and novel antibodies therefor | |
Girault et al. | Improving the quality of immunoblots by chromatography of polyclonal antisera on keratin affinity columns | |
ATE180282T1 (en) | ANTIBODIES TEST FOR DETECTING ALCOHOLICS AND MONITORING ALCOHOL INTAKE | |
CA2120342A1 (en) | Epstein-barr virus peptides and antibodies against these peptides | |
Ishikawa et al. | Highly sensitive enzyme immunoassay of rabbit (anti-human IgG) IgG using human IgG—β-D-galactosidase conjugate | |
WO2001015655A3 (en) | Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders | |
AU8630898A (en) | Antibodies and other binding molecules specific for hepatitis b viral antigens | |
Sakakibara et al. | Relationship between urinary fibrinogen degradation products and various types of chronic nephritis | |
AU8008487A (en) | A method for determining the presence of substances of diagnostic relevance, in particular antibodies or antigens, by the ELISA method with photometric evaluation | |
SE9700745D0 (en) | Improved immunoassays and improved diagnostic methods and a kit to be used in the methods | |
IT8906606A0 (en) | IMMUNENZYMATIC TEST FOR THE RESEARCH AND DETERMINATION OF BOVINE ANTICASEIN ANTIBODIES IN SERUM | |
IE882302L (en) | Antigen fractions for detecting antibodies indicative of a¹cardiovascular risk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1993917471 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993917471 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1995 379489 Date of ref document: 19950710 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993917471 Country of ref document: EP |